Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07286890 · ClinicalTrials.gov registry record
Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study
A clinical trial of Off Pump Coronary Artery Bypass Surgery, sponsored by Maquet Cardiovascular.
- Recruiting
- Registry status
- 200
- Enrollment target
- 2
- Study locations
NCT07286890: Recruiting study of Off Pump Coronary Artery Bypass Surgery, sponsored by Maquet Cardiovascular.
NCT07286890 is a study of Off Pump Coronary Artery Bypass Surgery that is actively recruiting participants, run by Maquet Cardiovascular. The registered enrollment target is 200 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07286890, a study of Off Pump Coronary Artery Bypass Surgery, is actively recruiting participants, sponsored by Maquet Cardiovascular.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
This observational study aims to collect data on the performance and safety of Getinge's Beating Heart products used during open-heart coronary artery bypass graft surgery. The surgery and the use of the study devices will be done according to the standard of care. Participants will not be required to undergo any study-specific procedures, and information will be collected only until hospital discharge following the surgery.
Primary Outcome
Incidence of device-related adverse events for each subject
Conditions Studied
Interventions
- DEVICE Vacuum Stabilizer System
- DEVICE Vacuum Positioner System
- DEVICE Blower/Mister
- DEVICE Proximal Seal System
Study Locations (2)
California
- St. Joseph's Medical Center Stockton - Stockton
Wisconsin
- Aspirus Medical Group - Wausau
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-03-04 |
| Est. Completion | 2026-12 |
What NCT07286890 shows while recruiting
NCT07286890 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Off Pump Coronary Artery Bypass Surgery appearing as the primary indexed condition, and to 4 interventions - of which Vacuum Stabilizer System is the first listed.
NCT07286890 reports a single indexed study location in California, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07286890 about?
NCT07286890 is a clinical study titled "Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study". This observational study aims to collect data on the performance and safety of Getinge's Beating Heart products used during open-heart coronary artery bypass graft surgery. The surgery and the use of the study devices will be done according to the standard of care. Participants will not be required ...
What is the current status of trial NCT07286890?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2026-03-04. Estimated completion is 2026-12.
What conditions does trial NCT07286890 study?
This clinical trial studies the following conditions: Off Pump Coronary Artery Bypass Surgery.
What interventions are being tested in trial NCT07286890?
The interventions under investigation include: Vacuum Stabilizer System (DEVICE), Vacuum Positioner System (DEVICE), Blower/Mister (DEVICE), Proximal Seal System (DEVICE).
Who is sponsoring clinical trial NCT07286890?
This trial is sponsored by Maquet Cardiovascular, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07286890 being conducted?
This trial has 2 study locations across California, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI